Detalhe da pesquisa
1.
Synthetic Glabridin Derivatives Inhibit LPS-Induced Inflammation via MAPKs and NF-κB Pathways in RAW264.7 Macrophages.
Molecules
; 28(5)2023 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36903379
2.
Accelerated aging phenotypes in the retinal pigment epithelium of Zmpste24-deficient mice.
Biochem Biophys Res Commun
; 632: 62-68, 2022 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36201882
3.
Discovery and preclinical efficacy of HSG4112, a synthetic structural analog of glabridin, for the treatment of obesity.
Int J Obes (Lond)
; 45(1): 130-142, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32943760
4.
Vutiglabridin Alleviates Cellular Senescence with Metabolic Regulation and Circadian Clock in Human Dermal Fibroblasts.
Antioxidants (Basel)
; 13(1)2024 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38247533
5.
Paraoxonase-2 agonist vutiglabridin promotes autophagy activation and mitochondrial function to alleviate non-alcoholic steatohepatitis.
Br J Pharmacol
; 2024 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38852992
6.
Vutiglabridin Modulates Paraoxonase 1 and Ameliorates Diet-Induced Obesity in Hyperlipidemic Mice.
Biomolecules
; 13(4)2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37189434
7.
Paraoxonase-2 contributes to promoting lipid metabolism and mitochondrial function via autophagy activation.
Sci Rep
; 12(1): 21483, 2022 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509805